Ascendis Pharma A/S filed a Form 6-K to report a change in the ISIN for its ordinary shares following their direct listing on The Nasdaq Global Select Market.
Key takeaways
The company's ordinary shares now have a new International Securities Identification Number (ISIN) of DK0060615755, as confirmed by Denmark's National Numbering Agency.
The previous ISIN, DK0060606333, is no longer applicable following the direct listing on Nasdaq.
The CUSIP number (K08588103) and ticker symbol (ASND) for the company's ordinary shares remain unchanged from previous disclosures.
The report is incorporated by reference into the company's existing Form S-8 and Form F-3 registration statements.